Impact of Mayzent on aSPMS Patients in a Long-term NIS in Italy

Clinical trial NCT05376579 · COMPLETED

Trial details

NCT number: NCT05376579
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Active Secondary Progressive Multiple Sclerosis

Start date: 2022-06-17
Primary completion: 2025-07-22
Enrollment: 134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.